Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

64.38
Delayed Data
As of Apr 29
 -1.58 / -2.40%
Today’s Change
47.92
Today|||52-Week Range
103.29
-21.39%
Year-to-Date

Today’s Trading

Previous close65.96
Today’s open65.67
Day’s range62.64 - 65.67
Volume1,155,589
Average volume (3 months)902,793
Market cap$5.5B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)+2.04%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book24.36

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-1.07-1.48%
ABMDAbiomed Inc-2.80-2.80%
NUVANuVasive Inc-0.16-0.30%
IARTIntegra LifeSciences...+0.70+1.00%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Chief Operating Officer &
Director
Kevin Ronald Sayer
Chief Financial Officer &
Senior Vice President
Jess Roper
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs